Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 186

    1.

    [Glycated haemoglobin may in future be reported as estimated mean blood glucose concentration--secondary publication]

    Borg R, Nerup J, Nathan DM, Kuenen J, Zheng H, Schoenfeld D, Heine RJ; ADAG-studiegruppen.

    Ugeskr Laeger. 2009 Nov 2;171(45):3262-5. Danish. PMID: 19916193 [PubMed - in process]Related articles

    2.

    10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

    Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM.

    Lancet. 2009 Nov 14;374(9702):1677-86. Epub 2009 Oct 29.PMID: 19878986 [PubMed - in process]Related articles

    3.

    The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans.

    Hivert MF, Sullivan LM, Shrader P, Fox CS, Nathan DM, D'Agostino RB Sr, Wilson PW, Benjamin EJ, Meigs JB.

    Metabolism. 2009 Oct 19. [Epub ahead of print]PMID: 19846171 [PubMed - as supplied by publisher]Related articles

    4.

    The clinical application of genetic testing in type 2 diabetes: a patient and physician survey.

    Grant RW, Hivert M, Pandiscio JC, Florez JC, Nathan DM, Meigs JB.

    Diabetologia. 2009 Sep 2. [Epub ahead of print]PMID: 19727660 [PubMed - as supplied by publisher]Related articles

    5.

    Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).

    Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, Orchard TJ.

    Arch Intern Med. 2009 Jul 27;169(14):1307-16.PMID: 19636033 [PubMed - indexed for MEDLINE]Related articles

    6.

    Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus.

    Ai M, Otokozawa S, Schaefer EJ, Asztalos BF, Nakajima K, Shrader P, Kathiresan S, Meigs JB, Williams G, Nathan DM.

    Clin Chim Acta. 2009 Aug;406(1-2):71-4. Epub 2009 May 22.PMID: 19465013 [PubMed - indexed for MEDLINE]Related articles

    7.

    Progress in diabetes research--what's next.

    Nathan DM.

    JAMA. 2009 Apr 15;301(15):1599-601. No abstract available. PMID: 19366783 [PubMed - indexed for MEDLINE]Related articles

    8.

    Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.

    Myocardial Infarction Genetics Consortium, Kathiresan S, Voight BF, Purcell S, Musunuru K, Ardissino D, Mannucci PM, Anand S, Engert JC, Samani NJ, Schunkert H, Erdmann J, Reilly MP, Rader DJ, Morgan T, Spertus JA, Stoll M, Girelli D, McKeown PP, Patterson CC, Siscovick DS, O'Donnell CJ, Elosua R, Peltonen L, Salomaa V, Schwartz SM, Melander O, Altshuler D, Ardissino D, Merlini PA, Berzuini C, Bernardinelli L, Peyvandi F, Tubaro M, Celli P, Ferrario M, Fetiveau R, Marziliano N, Casari G, Galli M, Ribichini F, Rossi M, Bernardi F, Zonzin P, Piazza A, Mannucci PM, Schwartz SM, Siscovick DS, Yee J, Friedlander Y, Elosua R, Marrugat J, Lucas G, Subirana I, Sala J, Ramos R, Kathiresan S, Meigs JB, Williams G, Nathan DM, MacRae CA, O'Donnell CJ, Salomaa V, Havulinna AS, Peltonen L, Melander O, Berglund G, Voight BF, Kathiresan S, Hirschhorn JN, Asselta R, Duga S, Spreafico M, Musunuru K, Daly MJ, Purcell S, Voight BF, Purcell S, Nemesh J, Korn JM, McCarroll SA, Schwartz SM, Yee J, Kathiresan S, Lucas G, Subirana I, Elosua R, Surti A, Guiducci C, Gianniny L, Mirel D, Parkin M, Burtt N, Gabriel SB, Samani NJ, Thompson JR, Braund PS, Wright BJ, Balmforth AJ, Ball SG, Hall AS; Wellcome Trust Case Control Consortium, Schunkert H, Erdmann J, Linsel-Nitschke P, Lieb W, Ziegler A, König I, Hengstenberg C, Fischer M, Stark K, Grosshennig A, Preuss M, Wichmann HE, Schreiber S, Schunkert H, Samani NJ, Erdmann J, Ouwehand W, Hengstenberg C, Deloukas P, Scholz M, Cambien F, Reilly MP, Li M, Chen Z, Wilensky R, Matthai W, Qasim A, Hakonarson HH, Devaney J, Burnett MS, Pichard AD, Kent KM, Satler L, Lindsay JM, Waksman R, Epstein SE, Rader DJ, Scheffold T, Berger K, Stoll M, Huge A, Girelli D, Martinelli N, Olivieri O, Corrocher R, Morgan T, Spertus JA, McKeown P, Patterson CC, Schunkert H, Erdmann E, Linsel-Nitschke P, Lieb W, Ziegler A, König IR, Hengstenberg C, Fischer M, Stark K, Grosshennig A, Preuss M, Wichmann HE, Schreiber S, Hólm H, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Engert JC, Do R, Xie C, Anand S, Kathiresan S, Ardissino D, Mannucci PM, Siscovick D, O'Donnell CJ, Samani NJ, Melander O, Elosua R, Peltonen L, Salomaa V, Schwartz SM, Altshuler D.

    Nat Genet. 2009 Mar;41(3):334-41. Epub 2009 Feb 8.PMID: 19198609 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial.

    Delahanty LM, Nathan DM, Lachin JM, Hu FB, Cleary PA, Ziegler GK, Wylie-Rosett J, Wexler DJ; Diabetes Control and Complications Trial/Epidemiology of Diabetes.

    Am J Clin Nutr. 2009 Feb;89(2):518-24. Epub 2008 Dec 23.PMID: 19106241 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study.

    Paré G, Chasman DI, Parker AN, Nathan DM, Miletich JP, Zee RY, Ridker PM.

    PLoS Genet. 2008 Dec;4(12):e1000312. Epub 2008 Dec 19.PMID: 19096518 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.

    White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, Hubbard LD, Lachin JM, Nathan DM.

    Arch Ophthalmol. 2008 Dec;126(12):1707-15.PMID: 19064853 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Glycemic management of type 2 diabetes: how tight is right and how to get there.

    Nathan DM.

    Arch Intern Med. 2008 Oct 27;168(19):2064-6. No abstract available. PMID: 18955633 [PubMed - indexed for MEDLINE]Related articles

    13.

    Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.

    Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for Study of Diabetes.

    Diabetes Care. 2009 Jan;32(1):193-203. Epub 2008 Oct 22.PMID: 18945920 [PubMed - in process]Related articlesFree article

    14.

    Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

    Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for the Study of Diabetes.

    Diabetologia. 2009 Jan;52(1):17-30. Epub 2008 Oct 22.PMID: 18941734 [PubMed - indexed for MEDLINE]Related articles

    15.

    Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial.

    Lin J, Glynn RJ, Rifai N, Manson JE, Ridker PM, Nathan DM, Schaumberg DA.

    Diabetes Care. 2008 Dec;31(12):2338-43. Epub 2008 Sep 16.PMID: 18796620 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening.

    Ginde AA, Cagliero E, Nathan DM, Camargo CA Jr.

    Acad Emerg Med. 2008 Dec;15(12):1241-7. Epub 2008 Sep 8.PMID: 18785943 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of diabetes.

    Wexler DJ, Nathan DM, Grant RW, Regan S, Van Leuvan AL, Cagliero E.

    J Clin Endocrinol Metab. 2008 Nov;93(11):4238-44. Epub 2008 Aug 12.PMID: 18697862 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004.

    Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS, Sullivan L, D'Agostino RB, Nathan DM.

    Diabetes Care. 2008 Oct;31(10):1991-6. Epub 2008 Jul 15.PMID: 18628569 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population.

    Ginde AA, Cagliero E, Nathan DM, Camargo CA Jr.

    J Gen Intern Med. 2008 Sep;23(9):1346-53. Epub 2008 Jun 10.PMID: 18543044 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Translating the A1C assay into estimated average glucose values.

    Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group.

    Diabetes Care. 2008 Aug;31(8):1473-8. Epub 2008 Jun 7. Erratum in: Diabetes Care. 2009 Jan;32(1):207. PMID: 18540046 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Measuring psychological insulin resistance: barriers to insulin use.

    Larkin ME, Capasso VA, Chen CL, Mahoney EK, Hazard B, Cagliero E, Nathan DM.

    Diabetes Educ. 2008 May-Jun;34(3):511-7.PMID: 18535324 [PubMed - indexed for MEDLINE]Related articles

    22.

    Implications of the diabetes prevention program and Look AHEAD clinical trials for lifestyle interventions.

    Delahanty LM, Nathan DM.

    J Am Diet Assoc. 2008 Apr;108(4 Suppl 1):S66-72. Review.PMID: 18358260 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    The prevention of type 2 diabetes.

    Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, Haffner SM, Hoskin M, Nathan DM; Diabetes Prevention Program Research Group.

    Nat Clin Pract Endocrinol Metab. 2008 Jul;4(7):382-93. Epub 2008 May 20. Review.PMID: 18493227 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance.

    Hivert MF, Sullivan LM, Fox CS, Nathan DM, D'Agostino RB Sr, Wilson PW, Meigs JB.

    J Clin Endocrinol Metab. 2008 Aug;93(8):3165-72. Epub 2008 May 20.PMID: 18492747 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer.

    Smith MR, Lee H, Fallon MA, Nathan DM.

    Urology. 2008 Feb;71(2):318-22.PMID: 18308111 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited.

    Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN; DCCT/EDIC Research Group.

    Diabetes. 2008 Apr;57(4):995-1001. Epub 2008 Jan 25.PMID: 18223010 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%.

    Pani LN, Nathan DM, Grant RW.

    Diabetes Care. 2008 Mar;31(3):386-90. Epub 2007 Dec 14.PMID: 18083790 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Retinal haemodynamics in individuals with well-controlled type 1 diabetes.

    Lorenzi M, Feke GT, Cagliero E, Pitler L, Schaumberg DA, Berisha F, Nathan DM, McMeel JW.

    Diabetologia. 2008 Feb;51(2):361-4. Epub 2007 Nov 20.PMID: 18026927 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.

    Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B.

    Diabetologia. 2008 Jan;51(1):8-11. No abstract available. PMID: 18026926 [PubMed - indexed for MEDLINE]Related articles

    31.

    C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study.

    Zee RY, Germer S, Thomas A, Raji A, Rhees B, Ridker PM, Lindpaintner K, Williams GH, Nathan DM, Martin M.

    Atherosclerosis. 2008 Apr;197(2):931-6. Epub 2007 Sep 27.PMID: 17900590 [PubMed - indexed for MEDLINE]Related articles

    32.

    Relationship between glycated haemoglobin levels and mean glucose levels over time.

    Nathan DM, Turgeon H, Regan S.

    Diabetologia. 2007 Nov;50(11):2239-44. Epub 2007 Sep 13.PMID: 17851648 [PubMed - indexed for MEDLINE]Related articles

    33.

    A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.

    Nathan DM, Iser JH, Gibson PR.

    J Gastroenterol Hepatol. 2008 Jun;23(6):954-8. Epub 2007 Jun 7.PMID: 17559377 [PubMed - indexed for MEDLINE]Related articles

    34.

    Rosiglitazone and cardiotoxicity--weighing the evidence.

    Nathan DM.

    N Engl J Med. 2007 Jul 5;357(1):64-6. Epub 2007 Jun 5. No abstract available. PMID: 17551161 [PubMed - indexed for MEDLINE]Related articles

    35.

    Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.

    Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr.

    Arch Intern Med. 2007 May 28;167(10):1068-74.PMID: 17533210 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program.

    Lachin JM, Christophi CA, Edelstein SL, Ehrmann DA, Hamman RF, Kahn SE, Knowler WC, Nathan DM; DDK Research Group.

    Diabetes. 2007 Apr;56(4):1153-9.PMID: 17395752 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Trials that matter: rosiglitazone, ramipril, and the prevention of type 2 diabetes.

    Nathan DM, Berkwits M.

    Ann Intern Med. 2007 Mar 20;146(6):461-3. No abstract available. PMID: 17371892 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.

    Look AHEAD Research Group, Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, Curtis JM, Espeland MA, Foreyt JP, Graves K, Haffner SM, Harrison B, Hill JO, Horton ES, Jakicic J, Jeffery RW, Johnson KC, Kahn S, Kelley DE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montgomery B, Nathan DM, Patricio J, Peters A, Redmon JB, Reeves RS, Ryan DH, Safford M, Van Dorsten B, Wadden TA, Wagenknecht L, Wesche-Thobaben J, Wing RR, Yanovski SZ.

    Diabetes Care. 2007 Jun;30(6):1374-83. Epub 2007 Mar 15.PMID: 17363746 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the Diabetes Control and Complications Trial.

    Lachin JM, Genuth S, Nathan DM, Rutledge BN.

    Diabetes. 2007 Jul;56(7):1913-21. Epub 2007 Mar 14.PMID: 17360979 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists.

    Grant RW, Wexler DJ, Watson AJ, Lester WT, Cagliero E, Campbell EG, Nathan DM.

    Diabetes Care. 2007 Jun;30(6):1448-53. Epub 2007 Mar 2.PMID: 17337497 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Impaired fasting glucose and impaired glucose tolerance: implications for care.

    Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B; American Diabetes Association.

    Diabetes Care. 2007 Mar;30(3):753-9. Review. No abstract available. PMID: 17327355 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Finding new treatments for diabetes--how many, how fast... how good?

    Nathan DM.

    N Engl J Med. 2007 Feb 1;356(5):437-40. No abstract available. PMID: 17267901 [PubMed - indexed for MEDLINE]Related articles

    43.

    Counterpoint: No time to inhale: arguments against inhaled insulin in 2007.

    Nathan DM.

    Diabetes Care. 2007 Feb;30(2):442-3. No abstract available. PMID: 17259528 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals.

    Wexler DJ, Meigs JB, Cagliero E, Nathan DM, Grant RW.

    Diabetes Care. 2007 Feb;30(2):367-9. No abstract available. PMID: 17259511 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.

    Florez JC, Jablonski KA, Kahn SE, Franks PW, Dabelea D, Hamman RF, Knowler WC, Nathan DM, Altshuler D.

    Diabetes. 2007 Feb;56(2):531-6.PMID: 17259403 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.

    Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, Hamman RF, Knowler WC, Nathan DM, Altshuler D; Diabetes Prevention Program Research Group.

    J Clin Endocrinol Metab. 2007 Apr;92(4):1502-9. Epub 2007 Jan 9.PMID: 17213274 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure?

    Heine RJ, Diamant M, Mbanya JC, Nathan DM.

    BMJ. 2006 Dec 9;333(7580):1200-4. Review. No abstract available. PMID: 17158386 [PubMed - indexed for MEDLINE]Related articles

    48.

    Thiazolidinediones for initial treatment of type 2 diabetes?

    Nathan DM.

    N Engl J Med. 2006 Dec 7;355(23):2477-80. Epub 2006 Dec 4. No abstract available. PMID: 17145743 [PubMed - indexed for MEDLINE]Related articles

    49.

    The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

    Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM; DCCT/EDIC Research Group.

    Diabetes. 2006 Dec;55(12):3556-65.PMID: 17130504 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach.

    Nathan DM, Angus PW, Gibson PR.

    J Gastroenterol Hepatol. 2006 Sep;21(9):1366-71. Review.PMID: 16911678 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...